Trial Profile
Compassionate use of pergolide as adjunctive therapy to levodopa/carbidopa for treating Parkinson's Disease.
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 15 May 2019
Price :
$35
*
At a glance
- Drugs Pergolide (Primary)
- Indications Parkinson's disease
- Focus Expanded access; Therapeutic Use
- Sponsors Bausch Health Companies
- 21 Mar 2008 New trial record.